Microbiology

CLSI AST Stewardship Webinar

Guiding Stewardship With Thoughtful Antimicrobial Reporting - An Updated Approach for 2023 Webinar

Learn about improving antimicrobial stewardship with new approaches in thoughtful antimicrobial reporting. 

By participating in this program, you will learn about: 

  • The changes in the 33rd edition of M100, including those to Tables 1. 
  • Tables/information with CLSI Antifungal Susceptibility documents similar to Table 1 in M100. 
  • The work of the Antifungal Susceptibility Testing subcommittee WG on intrinsic resistance with examples of intrinsic antifungal resistance. 
  • Examples where the definition of intrinsic resistance is not met but antifungal susceptibility testing is still not recommended. 
  • Selecting antimicrobials to test and report for veterinary specimens.
January 21, 2023

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Overview of Changes

Learning Objectives

  • Discuss the forthcoming changes to Tables 1 for antimicrobial susceptibility testing (AST) test & report guidance.
  • Demonstrate how Tables 1 can be used to devise test and report strategies at the institutional level.
  • Review tables/information with CLSI Antifungal Susceptibility documents similar to Table 1 in M100.
  • Discuss work of AFST subcommittee WG on intrinsic resistance and provide examples of intrinsic antifungal resistance.
  • Provide examples where definition of intrinsic resistance is not met but antifungal susceptibility testing still not recommended.
Speakers
Moderated by
Nicole Scangarella-Oman, MS, Scientific Director, Clinical Microbiology Infectious Diseases Research Unit (IDRU), GSK
April M. Bobenchik, PhD, D(ABMM), MT(ASCP), Medical Director Microbiology, Associate Professor Pathology & Laboratory Medicine, Penn State Health, Milton S. Hershey Medical Center
Presenters
Patricia (Trish) Simner, PhD, D(ABMM), Director of Medical Bacteriology, Johns Hopkins University School of Medicine
Nathan P. Wiederhold, PharmD, Professor, Director Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio
Stephen Cole, VMD, MS, DACVM, Lecturer in Veterinary Microbiology, Penn Vet Philadelphia Clinical Microbiology Laboratory
Overview of Changes

Learning Objectives

  • Discuss the forthcoming changes to Tables 1 for antimicrobial susceptibility testing (AST) test & report guidance.
  • Demonstrate how Tables 1 can be used to devise test and report strategies at the institutional level.
  • Review tables/information with CLSI Antifungal Susceptibility documents similar to Table 1 in M100.
  • Discuss work of AFST subcommittee WG on intrinsic resistance and provide examples of intrinsic antifungal resistance.
  • Provide examples where definition of intrinsic resistance is not met but antifungal susceptibility testing still not recommended.
Speakers
Moderated by
Nicole Scangarella-Oman, MS, Scientific Director, Clinical Microbiology Infectious Diseases Research Unit (IDRU), GSK
April M. Bobenchik, PhD, D(ABMM), MT(ASCP), Medical Director Microbiology, Associate Professor Pathology & Laboratory Medicine, Penn State Health, Milton S. Hershey Medical Center
Presenters
Patricia (Trish) Simner, PhD, D(ABMM), Director of Medical Bacteriology, Johns Hopkins University School of Medicine
Nathan P. Wiederhold, PharmD, Professor, Director Fungus Testing Laboratory, University of Texas Health Science Center at San Antonio
Stephen Cole, VMD, MS, DACVM, Lecturer in Veterinary Microbiology, Penn Vet Philadelphia Clinical Microbiology Laboratory